Clinical trial
CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
NCT04691713 is registered in ClinicalTrials.gov with PersonGen BioTherapeutics (Suzhou) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
- Lead sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 1, 2019
- Completion date
- December 1, 2021
- Enrollment
- 5 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
car, solid tumor